Jim Crumly

Jim Crumly

TMFSpeyside

Jim bought his first stocks in 1967 with paper route money and has been invested in equities ever since. He's still learning, though, and enjoys studying and investing in a wide variety of businesses. He has a BS and MS in electrical engineering from Stanford University, and retired after 34 years with a large technology company.

Recent articles







A Double Failure of Alzheimer's Drugs

Lilly and Roche reported their latest disappointments in attempting to effectively treat Alzheimer's by attacking amyloid plaques.




Merck Announces a Big Planned Spinoff

The pharma giant will form a new publicly traded company out of its women's health and biosimilars businesses, and its legacy brands.








Is Zoetis Stock a Buy?

Solid growth prospects make this animal health company an investor favorite, but don't forget to examine the price you'd pay.